Company: ABUS
Filing Date: 2025-05-23
Form Type: 8-K
Source: 0001447028-25-000104
Chunk: 0

Company: Arbutus Biopharma Corp
Filing Date: 2025-05-23
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 21, 2025

  Proposal 1.      To elect the five director nominees named in the Proxy Statement/Circular each to serve until the 2026 Annual General Meeting of Shareholders or until his or her qualified successor has been du...  

  Nominee                                   Votes          Votes          Broker  
                                              For       Withheld       Non-Votes  
 ──────────────────────────────────────────────────────────────────────────────────
  Lindsay Androski, JD, MBA, CFA      123,784,223      6,331,634      28,231,130  
  Robert Alan Beardsley               124,837,983      5,277,874      28,231,130  
  Joseph Bishop                       122,059,590      8,056,267      28,231,130  
  Matthew Gline                       122,656,045      7,459,812      28,231,130  
  Anuj Hasija                         124,821,361      5,294,496      28,231,130  

  Proposal 2.      To approve, by non-binding advisory vote, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement/Circular:  

        Votes      Votes Against          Votes          Broker  
          For                         Abstained       Non-Votes  
 ─────────────────────────────────────────────────────────────────
  122,791,749          6,976,561        347,547      28,231,130  

  Proposal 3.      To approve the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025:  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

        Votes      Votes Against          Votes      Broker     
          For                         Abstained      Non-Votes  
 ────────────────────────────────────────────────────────────────
  157,702,833            486,002        158,152      —          

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 23, 2025